|
|
||||||||
release assay testing for the treatment of latent tuberculosis1 School of Public Health, University of Düsseldorf, Germany, 2 Oxford Immunotec, Oxford, UK, 3 University Medical Policlinic, Lausanne, Switzerland.
CORRESPONDENCE: R. Diel, School of Public Health, c/o Institute for Medical Sociology, Heinrich Heine University, Post box 101007, D-40001 Düsseldorf, Germany. Fax: 49 40427907185. E-mail: Roland.Diel{at}uni-duesseldorf.de
Keywords: Cost-effectiveness, interferon-
release assay, latent tuberculosis infection, latent tuberculosis infection treatment, tuberculosis
Received: November 7, 2006
Accepted April 19, 2007
The aim of the present study was to assess the cost-effectiveness of the new T-SPOT.TB assay versus the tuberculin skin test (TST) for screening contacts for latent tuberculosis (TB) infection in Switzerland.
Health and economic outcomes of isoniazid treatment of 20- and 40-yr-old close contacts were compared in a Markov model over a 20-yr period following screening with TST only (at three cut-off values) and T-SPOT.TB alone or in combination with the TST.
T-SPOT.TB-based treatment was cost-effective at \#8342;11,621 and \#8342;23,692 per life-year-gained (LYG) in the younger and older age group, respectively. No TST-based programmes were cost-effective, except at a 15-mm cut-off in the younger group only, where the cost-effectiveness (\#8342;26,451·LYG–1) fell just below the willingness-to-pay threshold. Combination of the TST with T-SPOT.TB slightly reduced the total cost compared with the T-SPOT.TB alone by 4.4 and 5.0% in the younger and older groups respectively. The number of contacts treated to avoid one case of TB decreased from 50 (95% confidence interval 32–106) with the TST (10-mm cut-off) to 18 (95%CI 11–43) if T-SPOT.TB was used.
Using T-SPOT.TB alone or in combination with the tuberculin skin test for screening of close contacts before latent tuberculosis infection treatment is highly cost-effective in reducing the disease burden of tuberculosis.
This article has been cited by other articles:
![]() |
S. G. Rhodes, T. Gruffydd-Jones, D. Gunn-Moore, and K. Jahans Interferon-{gamma} test for feline tuberculosis Vet Rec., April 5, 2008; 162(14): 453 - 454. [Full Text] [PDF] |
||||
![]() |
D. Brodie, D. J. Lederer, J. S. Gallardo, S. H. Trivedi, J. N. Burzynski, and N. W. Schluger Use of an Interferon-{gamma} Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients Chest, April 1, 2008; 133(4): 869 - 874. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |